Ciechanover A - Search Results

1

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma.

Pasca S, Tomuleasa C, Teodorescu P, Ghiaur G, Dima D, Moisoiu V, Berce C, Stefan C, Ciechanover A, Einsele H. Pasca S, et al. Among authors: ciechanover a. Front Oncol. 2019 Oct 24;9:1137. doi: 10.3389/fonc.2019.01137. eCollection 2019. Front Oncol. 2019. PMID: 31709194 Free PMC article.

2

Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML.

Drula R, Iluta S, Gulei D, Iuga C, Dima D, Ghiaur G, Buzoianu AD, Ciechanover A, Tomuleasa C. Drula R, et al. Among authors: ciechanover a. Blood Rev. 2022 Nov;56:100971. doi: 10.1016/j.blre.2022.100971. Epub 2022 May 16. Blood Rev. 2022. PMID: 35595613 Free article. Review.

3

The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.

Gulei D, Drula R, Ghiaur G, Buzoianu AD, Kravtsova-Ivantsiv Y, Tomuleasa C, Ciechanover A. Gulei D, et al. Among authors: ciechanover a. Cancer Res. 2023 Jun 2;83(11):1762-1767. doi: 10.1158/0008-5472.CAN-22-3739. Cancer Res. 2023. PMID: 36880841 Review.

4

How multi-component cascades operate in cells: lessons from the ubiquitin system-containing liquid-separated condensates.

Fu A, Livneh I, Ciechanover A, Cohen-Kaplan V. Fu A, et al. Among authors: ciechanover a. Mol Cell Oncol. 2021 Oct 21;8(5):1989939. doi: 10.1080/23723556.2021.1989939. eCollection 2021. Mol Cell Oncol. 2021. PMID: 34859148 Free PMC article.

5

Protein Quality Control by Molecular Chaperones in Neurodegeneration.

Ciechanover A, Kwon YT. Ciechanover A, et al. Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017. Front Neurosci. 2017. PMID: 28428740 Free PMC article. Review.

6

The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression.

Kravtsova-Ivantsiv Y, Ciechanover A. Kravtsova-Ivantsiv Y, et al. Among authors: ciechanover a. Mol Cell Oncol. 2015 May 26;2(4):e1054552. doi: 10.1080/23723556.2015.1054552. eCollection 2015 Oct-Dec. Mol Cell Oncol. 2015. PMID: 27308511 Free PMC article.

7

CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways.

Kravtsova-Ivantsiv Y, Goldhirsh G, Ciechanover A. Kravtsova-Ivantsiv Y, et al. Among authors: ciechanover a. Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2416909121. doi: 10.1073/pnas.2416909121. Epub 2024 Dec 17. Proc Natl Acad Sci U S A. 2024. PMID: 39689179

8

HUWE1 ubiquitinates MyoD and targets it for proteasomal degradation.

Noy T, Suad O, Taglicht D, Ciechanover A. Noy T, et al. Among authors: ciechanover a. Biochem Biophys Res Commun. 2012 Feb 10;418(2):408-13. doi: 10.1016/j.bbrc.2012.01.045. Epub 2012 Jan 18. Biochem Biophys Res Commun. 2012. PMID: 22277673

9

Stress-induced polyubiquitination of proteasomal ubiquitin receptors targets the proteolytic complex for autophagic degradation.

Cohen-Kaplan V, Ciechanover A, Livneh I. Cohen-Kaplan V, et al. Among authors: ciechanover a. Autophagy. 2017 Apr 3;13(4):759-760. doi: 10.1080/15548627.2016.1278327. Epub 2017 Jan 25. Autophagy. 2017. PMID: 28121483 Free PMC article.

10

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Glickman MH, Ciechanover A. Glickman MH, et al. Among authors: ciechanover a. Physiol Rev. 2002 Apr;82(2):373-428. doi: 10.1152/physrev.00027.2001. Physiol Rev. 2002. PMID: 11917093 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters